Axsm premarket

Thinly traded nano cap Axsome Therapeutics (NASDAQ:AXSM) is up 23% premarket on increased volume following its announcement that its Phase 2/3 clinical trial, ADVANCE-1, evaluating AXS-05...

Axsm premarket. FDA grants Priority Review and sets PDUFA action goal date of August 22, 2021 NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc....

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Axsome Therapeutics (AXSM) In a report issued on October 6, Graig Suvannavejh from Mizuho Securities maintained a Buy rating on Axsome Therapeutics, with a price target of $100.00. The company’s ...NASDAQ:AXSM Axsome Therapeutics (AXSM) Stock Forecast, Price & News $66.51 -3.68 (-5.24%) (As of 10/12/2023 ET) Compare Today's Range $66.15 $70.36 50-Day Range $63.83 $82.21 52-Week Range $38.87 $91.29 Volume 599,613 shs Average Volume 856,507 shs Market Capitalization $3.14 billion P/E Ratio N/A Dividend Yield N/A Price Target $102.40Aug 23, 2021 · Axsome Therapeutics Inc (NASDAQ: AXSM) stock is rising in premarket due to an update for its US marketing application seeking approval for AXS-05 for major depressive disorder (MDD). The FDA ... Axsome Therapeutics, Inc. Common Stock (AXSM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Domino’s Pizza falls after earnings. Shares of Domino’s Pizza fell more than 2% in the premarket after the pizza delivery chain released its third-quarter results. The …Axsome Therapeutics (AXSM 1.22%) is something of a rarity in the biotech world because it's starting to spread its wings for the first time thanks to recently commercializing a couple of new drugs ...Earnings announcement* for AXSM: Feb 27, 2023. Axsome Therapeutics, Inc. is expected* to report earnings on 02/27/2023 before market open. The report will be for the fiscal Quarter ending Dec 2022 ...

Axsome Therapeutics Inc is near the top in its industry group according to InvestorsObserver.AXSM gets an overall rating of 84. That means it scores higher than 84 percent of stocks. Axsome Therapeutics Inc gets a 97 rank in the Biotechnology industry. Biotechnology is number 23 out of 148 industries.The stock of Axsome Therapeutics Inc (AXSM) has seen a -1.26% decrease in the past week, with a -13.60% drop in the past month, and a -9.67% decrease in the past quarter. The volatility ratio for the week is 4.34%, and the volatility levels for the past 30 days are at 4.07% for AXSM. The simple moving average for the last 20 days is -6.44% for ...Go to AXSM PRE-MARKET. You are about to leave and go to AXSM PRE-MARKET Confirm. People Also Ask. AXSM CRL AXSM Reddit AXSM PDUFA date Axsm call options AXSM short Axsm yahoo finance AXSM insider trading. Popular Search Web Page. AXSM - Axsome Therapeutics Inc. Stock Quote (U.S. - MarketWatch AXSM | Complete …Axsome Therapeutics Inc (NASDAQ: AXSM) stock is rising in premarket due to an update for its US marketing application seeking approval for AXS-05 for major depressive disorder (MDD). The FDA ...We would like to show you a description here but the site won’t allow us.Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that ...

NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous ...Laser Photonics (LASE) +44% announces implementation of first cleantech handheld laser blasting system for The Coca-Cola Company.WISeKey International (WKEY) +19% and Swiss Armed...AXSM Stock Quote Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield 1 day 5 days 10 days 1 month 3 months 6 months 1 year... Pre-Market Post-Market. Stocks Stocks. Market Pulse. Stock Market Overview ... AXSM earnings call for the period ending June 30, 2023. AXSM : 70.56 (+0.26 ...Axsome Therapeutics, Inc. (AXSM) NasdaqGM - NasdaqGM Real Time Price. Currency in USD Follow 2W 10W 9M 70.38 +1.78 (+2.59%) At close: 04:00PM EDT

Enemy blinders 3000.

We would like to show you a description here but the site won’t allow us.The company seems to be coming into its own. Axsome Therapeutics ( AXSM -4.34%) has had a transformative past 10 months. The biotech company started the year with no drugs on the market, and now ...Get Axsome Therapeutics Inc. (AXSM) share price today, stock analysis, price valuation, performance, fundamentals, market cap, shareholding, and financial ...Benzinga’s FDA calendar is a meaningfully designed, user friendly, dynamically updated and simplistic investment tool that is a ‘must-have’ for those looking to make money from the ...See All Market Activity. News + Insights. CLOSE

See All Market Activity. News + Insights. CLOSEShares of the Axsome Therapeutics, Inc. (AXSM) stock were soaring in the Pre-market following the release of the AXS-05 update. AXSM stock price saw a push of 24.58% to reach 28.86 a share at the time of this writing. The stock was also green in the previous trade and went up by 8.29% at closing. Let’s take a closer look at this stock.Immuron (NASDAQ:IMRN) +34% on new research agreement with the Naval Medical Research Center.The Stars Group (NASDAQ:TSG) +33% on merger offer.Axsome Therapeutics (NASDAQ:AXSM) +11% on...News Home Axsome Therapeutics Inc (AXSM) Up 12.62% in Premarket Trading. Monday, November 28, 2022 06:47 AM | InvestorsObserver Analysts. Mentioned in this article. AXSM 0.00%Axsome Therapeutics ( NASDAQ: AXSM) is a biopharmaceutical company with a rich pipeline of drugs being run in trials of talked about indications such as treatment-resistant depression (TRD) and ...... Pre-Market Post-Market. Stocks Stocks. Market Pulse. Stock Market Overview ... AXSM earnings call for the period ending June 30, 2023. AXSM : 70.56 (+0.26 ...Oct 12, 2023 · 11 analysts have issued 1 year price objectives for Axsome Therapeutics' stock. Their AXSM share price forecasts range from $81.00 to $180.00. On average, they expect the company's share price to reach $102.40 in the next year. This suggests a possible upside of 54.0% from the stock's current price. Axsome Therapeutics (NASDAQ: AXSM), a newly minted commercial-stage biopharma, is set for a strong session today. Specifically, the company's shares are up by a whopping 52% in pre-market trading ...In this conversation. Verified account Protected Tweets @; Suggested usersAxsome Therapeutics (NASDAQ:AXSM) initiated with Outperform rating at William Blair. Shares up 1% premarket. Canopy Growth (NYSE: CGC ) initiated with Market Perform rating at Oppenheimer.Oct 12, 2023 · 11 analysts have issued 1 year price objectives for Axsome Therapeutics' stock. Their AXSM share price forecasts range from $81.00 to $180.00. On average, they expect the company's share price to reach $102.40 in the next year. This suggests a possible upside of 54.0% from the stock's current price.

The stock of Axsome Therapeutics Inc (AXSM) has seen a -1.26% decrease in the past week, with a -13.60% drop in the past month, and a -9.67% decrease in the past quarter. The volatility ratio for the week is 4.34%, and the volatility levels for the past 30 days are at 4.07% for AXSM. The simple moving average for the last 20 days is -6.44% for ...

AXSM stock closed at $56.82 and is up $7.17 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. AXSM has a strong overall score of 83 meaning the stock holds a better value than 83% of stocks at its current price.By Colin Kellaher Shares of Axsome Therapeutics Inc. jumped more than 30% in premarket trading Monday after the biopharmaceutical...View live Axsome Therapeutics, Inc. chart to track its stock's price action. Find market predictions, AXSM financials and market news.See All Market Activity. News + Insights. CLOSEAxsome Therapeutics (AXSM) In a report issued on October 6, Graig Suvannavejh from Mizuho Securities maintained a Buy rating on Axsome Therapeutics, with a price target of $100.00. The company's ...Find the latest news headlines from Axsome Therapeutics, Inc. Common Stock (AXSM) at Nasdaq.com.Sign up. See new Tweets

Blank pfp icon.

Mva sample test.

Axsome Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time AXSM stock price.Jun 27, 2022 · The shares of Axsome Therapeutics (AXSM) added ~48% in the pre-market Monday after the clinical-stage biotech announced that it received the proposed labeling from the FDA regarding... Axsome Therapeutics ( AXSM -2.57%) stood out last year. The biotech began selling its first two products: Sunosi, a sleep disorder drug it acquired from Jazz Pharmaceuticals; and Auvelity, an ...Back to AXSM Overview About Latest Pre-Market Trades Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.Feb 13, 2023 · Shares of Axsome Therapeutics Inc. AXSM, +2.00% tumbled about 10.0% in premarket trading on Monday after the company said in a securities filing that Teva Pharmaceutical Industries Ltd. TEVA, -0. ... The company beat estimates in the last four quarter, with the average earnings surprise being 12.29%. The stock is up 73.3% so far this year. Estimates for Gritstone improved from a loss per share ...Mar 2, 2021 · Axsome Therapeutics (NASDAQ:AXSM) has risen ~14.5% in the pre-market after the company announced the FDA acceptance of its New Drug Application (“NDA”) for AXS-05 for the treatment of the ... See the latest Axsome Therapeutics Inc stock price (NASDAQ:AXSM), related news, valuation, dividends and more to help you make your investing decisions.Jun 27, 2022 · The following are the most active stocks for the pre-market session: CSCO's current last sale is 84.42% of the target price of $52. CL's current last sale is 97.99% of the target price of $82. ….

AXSM stock fares better after Case 2, with an expected return of 9.2% over the next month (21 trading days) under Case 1 (where the stock has just suffered a 5% loss over the previous week ...Axsome Therapeutics (AXSM) In a report issued on October 6, Graig Suvannavejh from Mizuho Securities maintained a Buy rating on Axsome Therapeutics, with a price target of $100.00. The company's ...The 12 analysts offering 12-month price forecasts for Axsome Therapeutics Inc have a median target of 107.26, with a high estimate of 180.00 and a low ...Oct 3, 2023 · Axsome shares, which closed Friday at $24.46, were recently changing hands at $32.49, up 32.8%, in premarket trading. Write to Colin Kellaher at [email protected] (END) Dow Jones Newswires Axsome Therapeutics (AXSM) stock is taking a beating on Monday as rival Teva Pharmaceutical (TEVA) prepares a generic depression drug. The 7 Hottest Biotech …About Press Copyright Contact us Creators Advertise Developers Terms Press Copyright Contact us Creators Advertise Developers TermsPremarket on watch: $TSLA $NVDA $AXSM $COIN $FL $BBBY Premarket breakdown everyday 8:00-9:30am ET. Breakdown of the Macro Environment, Market, Commodities, FAANG ...Axsome Therapeutics (NASDAQ:AXSM) has risen ~14.5% in the pre-market after the company announced the FDA acceptance of its New Drug Application (“NDA”) for AXS-05 for the treatment of the ... Axsm premarket, Pre-Market Quotes; Nasdaq-100; Symbol Screener; Online Brokers; Glossary; Sustainable Bond Network; Symbol Change History; IPO Performance; Ownership Search; Dividend …, Axsome Therapeutics (NASDAQ:AXSM) initiated with an Outperform rating and a $95 ... (21% upside) price target at Piper Sandler. No premarket trading activity as yet in U.S. Recommended For You., Axsome Therapeutics GAAP EPS of -$1.54 misses by $0.30, revenue of $46.7M beats by $5.75M. Markets Insider Automation 50d., By Colin Kellaher Shares of Axsome Therapeutics Inc. jumped more than 30% in premarket trading Monday after the biopharmaceutical..., May 8, 2023 ... Axsome Therapeutics (NASDAQ:AXSM) added ~6% pre-market after its Q1 2023 results on Monday as investors turned attention to sales of its ..., What happened. Shares of Axsome Therapeutics ( AXSM -5.24%), a mid-cap biotech, are down by a hefty 41.4% as of 10:08 a.m. EDT Monday morning. The drugmaker's shares are tumbling today in response ..., Pre-Market Quotes; Nasdaq-100; Symbol Screener; Online Brokers; Glossary; Sustainable Bond Network; Symbol Change History; IPO Performance; Ownership Search; Dividend …, Where the stock market will trade today based on Dow Jones Industrial Average, S&P 500 and Nasdaq-100 futures and implied open premarket values. Commodities, currencies and global indexes also shown., Shares of Axsome Therapeutics (AXSM 1.22%) are down more than 10% in late-afternoon trading after the Food and Drug Administration (FDA) pulled the breakthrough therapy designation of its AXS-12 drug., axsm stock pre market Revenu de solidarité active - Wikipedia WebThe RSA has been at the forefront of significant social impact for over 260 years., Jun 27, 2022 · The following are the most active stocks for the pre-market session: CSCO's current last sale is 84.42% of the target price of $52. CL's current last sale is 97.99% of the target price of $82. , Axsome Therapeutics (AXSM) stock is on the rise Tuesday as the company edges closer to its first drug approval from the FDA. Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ..., The company beat estimates in the last four quarter, with the average earnings surprise being 12.29%. The stock is up 73.3% so far this year. Estimates for Gritstone improved from a loss per share ..., May 8, 2023 · May 8, 2023 at 7:00 AM · 14 min read. Axsome Therapeutics, Inc. Auvelity® 1Q 2023 net product sales of $15.7 million. Total 1Q 2023 net product sales of $28.6 million. Total 1Q 2023 revenue of ... , Jun 28, 2023 · Axsome Therapeutics is selling 3 million shares of AXSM stock at a price of $75 each. This helps explain why the stock is down today, as its prior closing price was sitting at $83.37 per share ... , About Press Copyright Contact us Creators Advertise Developers Terms Press Copyright Contact us Creators Advertise Developers Terms, Axsome Therapeutics, Inc. Common Stock (AXSM) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets., AXSM stock closed at $56.82 and is up $7.17 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. AXSM has a strong overall score of 83 meaning the stock holds a better value than 83% of stocks at its current price. InvestorsObserver's ..., Oct 11, 2023 · Axsome Therapeutics GAAP EPS of -$1.41 misses by $0.28, revenue of $24.37M beats by $2.49M. SA NewsMon, Feb. 27 4 Comments. , News Home Axsome Therapeutics Inc (AXSM) Up 12.62% in Premarket Trading. Monday, November 28, 2022 06:47 AM | InvestorsObserver Analysts. Mentioned in this article. AXSM 0.00%, View the latest Axsome Therapeutics Inc. (AXSM) stock price, news, historical charts, analyst ratings and financial information from WSJ. , Axsome Therapeutics ( AXSM) expects its eight products to generate up to $11.5 billion in peak U.S. sales, the company said in a filing that sent AXSM stock zooming higher Wednesday. This is the ..., MSP Recovery ( MSPR) +22% Member Lives in 2014, to More Than 34 Million Unique Healthcare Member Lives, as Well as Significant Advancements in Its Technological Capabilities, Including the ..., Find the latest Axsome Therapeutics, Inc. (AXSM) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. , Apr 25, 2022 · The shares of Axsome Therapeutics (NASDAQ:AXSM) have dropped ~26% in the pre-market Monday after the clinical-stage pharmaceutical company announced that the U.S. Food and Drug Administration (FDA ... , Axsome Therapeutics GAAP EPS of -$1.54 misses by $0.30, revenue of $46.7M beats by $5.75M. Markets Insider Automation 50d., Premarket Trading After Hours Trading Market Movers S&P 500 Volume Burst Trades 52-Week Highs & Lows Stock Order Imbalance Unusual Stock Volume Morning Report Company Events Market Action Lists Top Gainers on High Volume Top Losers on High Volume Outperforming Stocks Gap Up and Go Gap Down and Go, Shares of Axsome Therapeutics Inc. jumped 15.5% in premarket trading on Monday after the company said its Alzheimer's treatment candidate met the primary and secondary endpoints in a Phase 3 ..., NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the …, In this conversation. Verified account Protected Tweets @; Suggested users, Compared to the opening price on Monday 10/09/2023 on NAS of $70.43, this is a gain of 0.18%. Axsome Therapeutics Inc's market capitalization is $3.32 B by …, Axsome Therapeutics, Inc. Common Stock (AXSM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets., TTOO. T2 Biosystems, Inc. Common Stock. $0.2229 +0.002 +0.91%. Axsome Therapeutics, Inc. Common Stock (AXSM) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading ...